[Home ] [Archive]   [ فارسی ]  
:: Volume 21, Issue 1 (Iranian Journal of Ophthalmology 2009) ::
2009, 21(1): 3-14 Back to browse issues page
Longitudinal Study of Chlorambucil in Ocular Manifestations of Behçet’s Disease
Fereydoun Davatchi Dr. *, Hormoz Chams Dr., Farhad Shahram Dr., Abdol-Hadi Nadji Dr., Cheyda Chams-Davatchi Dr., Bahar Sadeghi-Abdollahi Dr., Masoumeh Akhlaghi Dr., Tahereh Faeizi Dr., Ahmad-Reza Jamshidi Dr., Mahmood Akbarian Dr.
, fddh@davatchi.net
Abstract:   (15334 Views)

Purpose : Cytotoxic drugs are the gold standard and the first line treatment for ophthalmological manifestations of Behçet’s Disease (BD). The purpose of this study was to evaluate the outcome of eyes with chlorambucil on long-term follow-up, in a longitudinal study on 15 years.

Methods : Chlorambucil was given as 0.2 to 0.3 mg per kilogram of body weight and per day. Prednisolone was concomitantly given as 0.5 mg per kilogram of body weight. Prednisolone was tapered later according to the improvement of inflammation. In refractory cases, the patient was switched to another cytotoxic drug. Visual acuity (VA) was calculated on a Snellen chart (on a scale of 10). A Disease Activity Index (DAI) was calculated for anterior uveitis (AU), posterior uveitis (PU), and retinal vasculitis (RV) according to Ben Ezra. The Total Inflammatory Activity Index (TIAI) and the Total Adjusted Disease Activity Index (TADAI) were also calculated. Results, before the treatment and after different intervals (from 3 months to 15 years), were compared together by the student paired t test. Confidence interval (CI) at 95% was calculated for percentages.

Results : Eighty nine patients received chlorambucil. The mean duration of treatment was 26.2 months ±2.6. Good results (stabilized or improved eyes from the baseline to last evaluation) were: VA 68.4%, PU 87.6%, RV 75.8%, TIAI 85.4%, TADAI 76.4%. The mean VA improved from 2.6 to 3.3, mean PU improved from 1.8 to 0.7, mean RV improved from 2.1 to 1.5, mean TIAI improved from 13.9 to 7.6, and mean TADAI improved from 21.5 to 16.2. The difference was statistically significant for all parameters. Longitudinal study showed maintenance of good results all over the study time.

Conclusion : Chlorambucil with prednisolone was effective in ocular lesions of BD. Good results were maintained on long-term follow-up.

 

Iranian Journal of Ophthalmology 200921(1):3-14 © 2009 by the Iranian Society of Ophthalmology
Keywords: Behçet’s Disease, Ocular Manifestations, Cytotoxic Therapy, Chlorambucil
Full-Text [PDF 175 kb]   (3368 Downloads)    
Type of Study: Original | Subject: General
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Davatchi F, Chams H, Shahram F, Nadji A, Chams-Davatchi C, Sadeghi-Abdollahi B, et al . Longitudinal Study of Chlorambucil in Ocular Manifestations of Behçet’s Disease. Iranian Journal of Ophthalmology. 2009; 21 (1) :3-14
URL: http://irjo.org/article-1-201-en.html


Volume 21, Issue 1 (Iranian Journal of Ophthalmology 2009) Back to browse issues page
مجله چشم پزشکی ایران Iranian Journal of Ophthalmology
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 4075